Skip to main content

Table 4 Association analysis of rs7761846 within ESR1 under a dominant model in ER-positive case analysis

From: Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

Sample Control Case OR (95% CI) Pvalue
Swedish 1,442 675 1.43 (1.10, 1.86) 0.007
Finnish 1,246 1669 1.10 (0.81, 1.48) 0.55
Combineda 2,688 2344 1.28 (1.05, 1.56) 0.014
  1. ER, estrogen receptor; OR, odds ratio; CI, confidence interval. aCombined analysis was performed on logistic regression adjusted by age and study.